共 50 条
- [3] Long-term Safety and Efficacy of Lasmiditan for Acute Treatment of Migraine over a One-Year Period: Interim Results of an Open-Label Phase 3 Study (GLADIATOR) [J]. HEADACHE, 2019, 59 : 121 - 121
- [5] Long-term treatment with lasmiditan in patients with migraine: Results from the open-label extension of the CENTURION study [J]. HEADACHE, 2022, 62 : 113 - 114
- [6] Long-Term Treatment With Lasmiditan in Patients With Migraine: Results From the Open-Label Extension of the CENTURION Study [J]. JOURNAL OF HEADACHE AND PAIN, 2022, 23 (SUPPL 1):
- [8] A phase 3, long-term, open-label safety study of Galcanezumab in patients with migraine [J]. BMC Neurology, 18